Keywords
Last Name

J. Mark Sloan, MD

TitleAssistant Professor
InstitutionBoston University School of Medicine
DepartmentMedicine
DivisionHematology & Medical Oncology
Address820 Harrison Ave
Boston MA 02118
Phone(617) 638-7520
ORCID ORCID Icon0000-0001-7069-4528
 Research Expertise & Professional Interests
My clinical expertise is in clinical hematology, especially lymphoma, leukemia, myeloma, amyloidosis, myelodysplasia and bone marrow transplantation. I also have expertise in the treatment of Jehovah's witnesses

 Self-Described Keywords
  • AL amyloidosis
  • Hodgkin Lymphoma
  • Leukemia
  • Multiple Myeloma
  • myelodysplasia
  • Non-Hodgkin Lymphoma
  • Thrombosis and IVC filters
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Sarosiek S, Rybin D, Weinberg J, Burke PA, Kasotakis G, Sloan JM. Association Between Inferior Vena Cava Filter Insertion in Trauma Patients and In-Hospital and Overall Mortality. JAMA Surg. 2017 Jan 01; 152(1):75-81. PMID: 27682367.
    View in: PubMed
  2. Bhatt N, Sloan JM, O'Hara CJ, Oommen R, Steiling K, Litle VR. Extranodal Marginal Zone Endobronchial Lymphoma Associated With Hepatitis C. Ann Thorac Surg. 2016 Nov; 102(5):e407-e408. PMID: 27772593.
    View in: PubMed
  3. Sanchorawala V, Shelton AC, Lo S, Varga C, Sloan JM, Seldin DC. Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial. Blood. 2016 Aug 25; 128(8):1059-62. PMID: 27381904.
    View in: PubMed
  4. Dittus C, Uwumugambi N, Sun F, Sloan JM, Sanchorawala V. The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 Sep; 22(9):1729-32. PMID: 27296954.
    View in: PubMed
  5. Muñoz-Largacha JA, O'Hara CJ, Sloan JM, Fernando HC, Litle VR. Surgical Management of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Associated With Light-Chain Deposition Disease. Ann Thorac Surg. 2016 Jun; 101(6):e207-10. PMID: 27211983.
    View in: PubMed
  6. Lee SY, Meehan RS, Seldin DC, Sloan JM, Quillen K, Shelton A, Brauneis D, Sanchorawala V. Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis. Bone Marrow Transplant. 2016 Oct; 51(10):1318-1322. PMID: 27183092.
    View in: PubMed
  7. Inagaki E, Farber A, Eslami MH, Siracuse JJ, Rybin DV, Sarosiek S, Sloan JM, Kalish J. Improving the retrieval rate of inferior vena cava filters with a multidisciplinary team approach. J Vasc Surg Venous Lymphat Disord. 2016 Jul; 4(3):276-82. PMID: 27318045.
    View in: PubMed
  8. Sissoko M, Sanchorawala V, Seldin D, Sworder B, Angelino K, Broce M, Berk J, Sloan JM. Clinical presentation and treatment responses in IgM-related AL amyloidosis. Amyloid. 2015; 22(4):229-35. PMID: 26488936.
    View in: PubMed
  9. Bever KM, Masha LI, Sun F, Stern L, Havasi A, Berk JL, Sanchorawala V, Seldin DC, Sloan JM. Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis. Haematologica. 2016 Jan; 101(1):86-90. PMID: 26452981.
    View in: PubMed
  10. Sanchorawala V, Sun F, Quillen K, Sloan JM, Berk JL, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience. Blood. 2015 Nov 12; 126(20):2345-7. PMID: 26443620.
    View in: PubMed
  11. Sanchorawala V, Brauneis D, Shelton AC, Lo S, Sun F, Sloan JM, Quillen K, Seldin DC. Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial. Biol Blood Marrow Transplant. 2015 Aug; 21(8):1445-51. PMID: 25858810.
    View in: PubMed
  12. Freeman B, Brauneis D, Seldin DC, Quillen K, Sloan JM, Renteria AS, Shelton AC, Teschner T, Finn KT, Sanchorawala V. Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis. Bone Marrow Transplant. 2014 Oct; 49(10):1345-6. PMID: 24955784.
    View in: PubMed
  13. Al-Malki MM, Castillo JJ, Sloan JM, Re A. Hematopoietic cell transplantation for plasmablastic lymphoma: a review. Biol Blood Marrow Transplant. 2014 Dec; 20(12):1877-84. PMID: 24946718.
    View in: PubMed
  14. Lee SY, Sanchorawala V, Seldin DC, Mark Sloan J, Andrea N, Quillen K. Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series. Amyloid. 2014 Sep; 21(3):149-53. PMID: 24779777.
    View in: PubMed
  15. von Keudell G, Sanchorawala V, O'Hara C, C Seldin D, Sloan JM. Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis. Amyloid. 2014 Jun; 21(2):124-7. PMID: 24471777.
    View in: PubMed
  16. Girnius S, Seldin DC, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V. Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplant. 2014 Mar; 49(3):434-9. PMID: 24317129.
    View in: PubMed
  17. Raman V, Quillen K, Sloan JM. Acquired Glanzmann thrombasthenia associated with Hodgkin lymphoma: rapid reversal of functional platelet defect with ABVD (adriamycin/bleomycin/vinblastine/dacarbazine) chemotherapy. Clin Lymphoma Myeloma Leuk. 2014 Apr; 14(2):e51-4. PMID: 24342105.
    View in: PubMed
  18. Sarosiek S, Crowther M, Sloan JM. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med. 2013 Apr 8; 173(7):513-7. PMID: 23552968.
    View in: PubMed
  19. Tsai SB, Seldin DC, Quillen K, Berk JL, Ruberg FL, Meier-Ewert H, Sloan JM, Doros G, Finn KT, Skinner M, Sanchorawala V. High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center. Blood. 2012 Nov 22; 120(22):4445-6. PMID: 23175664.
    View in: PubMed
  20. Sanchorawala V, Patel JM, Sloan JM, Shelton AC, Zeldis JB, Seldin DC. Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial. Haematologica. 2013 May; 98(5):789-92. PMID: 23144200.
    View in: PubMed
  21. Perry JH, Lazar HL, Quillen K, Sloan JM. Successful long-term management of aneurysm-associated chronic disseminated intravascular coagulation with low molecular weight heparin. J Card Surg. 2012 Nov; 27(6):730-5. PMID: 23173861.
    View in: PubMed
  22. Freeman B, Sloan JM, Seldin DC, Cowan AJ, Ruberg FL, Sanchorawala V. Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review. Amyloid. 2012 Sep; 19(3):156-60. PMID: 22680044.
    View in: PubMed
  23. Ryan RJ, Sloan JM, Collins AB, Mansouri J, Raje NS, Zukerberg LR, Ferry JA. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with amyloid deposition: a clinicopathologic case series. Am J Clin Pathol. 2012 Jan; 137(1):51-64. PMID: 22180478.
    View in: PubMed
  24. Sanchorawala V, Quillen K, Sloan JM, Andrea NT, Seldin DC. Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study. Haematologica. 2011 Dec; 96(12):1890-2. PMID: 21859734.
    View in: PubMed
  25. Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011 Oct 20; 118(16):4346-52. PMID: 21828140.
    View in: PubMed
  26. Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O'Connell R, O'Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid. 2011 Jun; 18 Suppl 1:127-9. PMID: 21838459.
    View in: PubMed
  27. Grayson PC, Sloan JM, Niles JL, Monach PA, Merkel PA. Antineutrophil cytoplasmic antibodies, autoimmune neutropenia, and vasculitis. Semin Arthritis Rheum. 2011 Dec; 41(3):424-33. PMID: 21507463.
    View in: PubMed
  28. Cowan AJ, Skinner M, Berk JL, Sloan JM, O'hara C, Seldin DC, Sanchorawala V. Macroglossia - not always AL amyloidosis. Amyloid. 2011 Jun; 18(2):83-6. PMID: 21401321.
    View in: PubMed
  29. Sanchorawala V, Seldin DC, Berk JL, Sloan JM, Doros G, Skinner M. Oral cyclic melphalan and dexamethasone for patients with AL amyloidosis. Clin Lymphoma Myeloma Leuk. 2010 Dec; 10(6):469-72. PMID: 21156464.
    View in: PubMed
  30. Patel TV, Rennke HG, Sloan JM, DeAngelo DJ, Charytan DM. A forgotten cause of kidney injury in chronic myelomonocytic leukemia. Am J Kidney Dis. 2009 Jul; 54(1):159-64. PMID: 19185401.
    View in: PubMed
  31. Sloan JM, Ballen K. SCT in Jehovah's Witnesses: the bloodless transplant. Bone Marrow Transplant. 2008 May; 41(10):837-44. PMID: 18246110.
    View in: PubMed
  32. Vinaya KN, White RI, Sloan JM. Reassessing bronchial artery embolotherapy with newer spherical embolic materials. J Vasc Interv Radiol. 2004 Mar; 15(3):304-5. PMID: 15028819.
    View in: PubMed
  33. Sloan JM, Kershaw MH, Touloukian CE, Lapointe R, Robbins PF, Restifo NP, Hwu P. MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells. Cancer Gene Ther. 2002 Nov; 9(11):946-50. PMID: 12386833.
    View in: PubMed
  34. Sloan JM, Allen DC, Hamilton PW, Watt PC. The place of quantitation in diagnostic gastrointestinal pathology. Curr Top Pathol. 1990; 81:177-216. PMID: 2407438.
    View in: PubMed
  35. Sloan JM, Raje, N. Anemia and Erythropoietic Growth Factors in Multiple Myeloma. Multiple Myeloma: Pursuing the Plasma Cell.
    View in: External Website
  36. Sloan, JM Seldin, D. Approach to Benign Hematologic Disorders. ACP Medicine.
    View in: External Website
J.'s Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department